You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2026 › May › 06
Mike Doustdar
47 days ago
Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before.
48 days ago
Novo Nordisk CEO: Aim is to expand weight-loss market in U.S. ⊕
found
a story from CNBC ⚠️ › World News
Charlotte Reed speaks with Mike Doustdar, CEO of Novo Nordisk, after the Danish comapny hiked its 2026 full-year guidance on the back of increased expectations for GLP-1 product sales.
page 1 of 1